{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:55:03Z","timestamp":1783814103350,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R15NS091934"],"award-info":[{"award-number":["R15NS091934"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A major characteristic of Alzheimer\u2019s disease (AD) is the accumulation of misfolded amyloid-\u03b2 (A\u03b2) peptide. Several studies linked AD with type 2 diabetes due to similarities between A\u03b2 and human amylin. This study investigates the effect of amylin and pramlintide on A\u03b2 pathogenesis and the predisposing molecular mechanism(s) behind the observed effects in TgSwDI mouse, a cerebral amyloid angiopathy (CAA) and AD model. Our findings showed that thirty days of intraperitoneal injection with amylin or pramlintide increased A\u03b2 burden in mice brains. Mechanistic studies revealed both peptides altered the amyloidogenic pathway and increased A\u03b2 production by modulating amyloid precursor protein (APP) and \u03b3-secretase levels in lipid rafts. In addition, both peptides increased levels of B4GALNT1 enzyme and GM1 ganglioside, and only pramlintide increased the level of GM2 ganglioside. Increased levels of GM1 and GM2 gangliosides play an important role in regulating amyloidogenic pathway proteins in lipid rafts. Increased brain A\u03b2 burden by amylin and pramlintide was associated with synaptic loss, apoptosis, and microglia activation. In conclusion, our findings showed amylin or pramlintide increase A\u03b2 levels and related pathology in TgSwDI mice brains, and suggest that increased amylin levels or the therapeutic use of pramlintide could increase the risk of AD.<\/jats:p>","DOI":"10.1038\/s41598-020-60664-5","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T11:02:41Z","timestamp":1582887761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Amylin and pramlintide modulate \u03b3-secretase level and APP processing in lipid rafts"],"prefix":"10.1038","volume":"10","author":[{"given":"Youssef M.","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-7766","authenticated-orcid":false,"given":"Amal","family":"Kaddoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"60664_CR1","first-page":"487","volume":"924","author":"DJ Selkoe","year":"2010","unstructured":"Selkoe, D. J. Toward a comprehensive theory for Alzheimer\u2019s disease. Hypothesis: Alzheimer\u2019s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N. Y. Acad. Sci. 924, 487\u2013498 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"60664_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nic.2011.11.003","volume":"22","author":"CR Harrington","year":"2012","unstructured":"Harrington, C. R. The Molecular Pathology of Alzheimer\u2019s Disease. Neuroimaging Clin. N. Am. 22, 11\u201322 (2012).","journal-title":"Neuroimaging Clin. N. Am."},{"key":"60664_CR3","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.R800019200","volume":"283","author":"G Thinakaran","year":"2008","unstructured":"Thinakaran, G. & Koo, E. H. Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 283, 29615\u201329619 (2008).","journal-title":"J. Biol. Chem."},{"key":"60664_CR4","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1242\/jcs.113.11.1857","volume":"113","author":"B De Strooper","year":"2000","unstructured":"De Strooper, B. & Annaert, W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113, 1857\u20131870 (2000).","journal-title":"J. Cell Sci."},{"key":"60664_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","volume":"107","author":"E Zenaro","year":"2017","unstructured":"Zenaro, E., Piacentino, G. & Constantin, G. The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol. Dis. 107, 41\u201356 (2017).","journal-title":"Neurobiol. Dis."},{"key":"60664_CR6","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata, M. et al. Clearance of Alzheimer\u2019s amyloid-\u03b21-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489\u20131499 (2000).","journal-title":"J. Clin. Invest."},{"key":"60664_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1046\/j.1460-9568.2003.02506.x","volume":"17","author":"J Gasic-Milenkovic","year":"2003","unstructured":"Gasic-Milenkovic, J. et al. \u03b2-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -\u03b3 and \u201cadvanced glycation endproducts\u201d in a murine microglia cell line. Eur. J. Neurosci. 17, 813\u2013821 (2003).","journal-title":"Eur. J. Neurosci."},{"key":"60664_CR8","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 1, a006189 (2011).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"60664_CR9","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0002-9440(10)63436-0","volume":"165","author":"KH Gylys","year":"2004","unstructured":"Gylys, K. H. et al. Synaptic changes in alzheimer\u2019s disease. increased amyloid-\u03b2 and gliosis in surviving terminals is accompanied by decreased psd-95 fluorescence. Am. J. Pathol. 165, 1809\u20131817 (2004).","journal-title":"Am. J. Pathol."},{"key":"60664_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1083\/jcb.200207113","volume":"160","author":"R Ehehalt","year":"2003","unstructured":"Ehehalt, R., Keller, P., Haass, C., Thiele, C. & Simons, K. Amyloidogenic processing of the Alzheimer \u03b2-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113\u2013123 (2003).","journal-title":"J. Cell Biol."},{"key":"60664_CR11","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/jnr.20981","volume":"84","author":"C Hattori","year":"2006","unstructured":"Hattori, C. et al. BACE1 interacts with lipid raft proteins. J. Neurosci. Res. 84, 912\u2013917 (2006).","journal-title":"J. Neurosci. Res."},{"key":"60664_CR12","doi-asserted-by":"publisher","first-page":"25892","DOI":"10.1074\/jbc.M503570200","volume":"280","author":"KS Vetrivel","year":"2005","unstructured":"Vetrivel, K. S. et al. Spatial segregation of \u03b3-secretase and substrates in distinct membrane domains. J. Biol. Chem. 280, 25892\u201325900 (2005).","journal-title":"J. Biol. Chem."},{"key":"60664_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1600-0854.2004.0181.x","volume":"5","author":"JB Helms","year":"2004","unstructured":"Helms, J. B. & Zurzolo, C. Lipids as targeting signals: Lipid rafts and intracellular trafficking. Traffic 5, 247\u2013254 (2004).","journal-title":"Traffic"},{"key":"60664_CR14","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/nm1095-1062","volume":"1","author":"K Yanagisawa","year":"1995","unstructured":"Yanagisawa, K., Odaka, A., Suzuki, N. & Ihara, Y. GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer\u2019s disease. Nat. Med. 1, 1062\u20131066 (1995).","journal-title":"Nat. Med."},{"key":"60664_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1385\/JMN:17:2:157","volume":"17","author":"R Vassar","year":"2001","unstructured":"Vassar, R. The \u03b2-secretase, BACE: A prime drug target for Alzheimer\u2019s disease. J. Mol. Neurosci. 17, 157\u2013170 (2001).","journal-title":"J. Mol. Neurosci."},{"key":"60664_CR16","doi-asserted-by":"publisher","first-page":"28110","DOI":"10.1074\/jbc.M414525200","volume":"280","author":"IY Tamboli","year":"2005","unstructured":"Tamboli, I. Y. et al. Inhibition of glycosphingolipid biosynthesis reduces secretion of the \u03b2-amyloid precursor protein and amyloid \u03b2-peptide. J. Biol. Chem. 280, 28110\u201328117 (2005).","journal-title":"J. Biol. Chem."},{"key":"60664_CR17","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.mp.4001509","volume":"9","author":"Q Zha","year":"2004","unstructured":"Zha, Q. et al. GM1 ganglioside regulates the proteolysis of amyloid precursor protein. Mol. Psychiatry 9, 946\u2013952 (2004).","journal-title":"Mol. Psychiatry"},{"key":"60664_CR18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.4239\/wjd.v5.i6.889","volume":"5","author":"M Barbagallo","year":"2014","unstructured":"Barbagallo, M. et al. Type 2 diabetes mellitus and Alzheimer\u2019s disease. World J. Diabetes 5, 889\u2013893 (2014).","journal-title":"World J. Diabetes"},{"key":"60664_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark, P., Andersson, A. & Westermark, G. T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 91, 795\u2013826 (2011).","journal-title":"Physiol. Rev."},{"key":"60664_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1615\/CritRevNeurobiol.v11.i2-3.40","volume":"11","author":"SJ Wimalawansa","year":"1997","unstructured":"Wimalawansa, S. J. et al. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit. Rev. Neurobiol. 11, 167\u2013239 (1997).","journal-title":"Crit. Rev. Neurobiol."},{"key":"60664_CR21","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJS Cooper","year":"1987","unstructured":"Cooper, G. J. S. et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84, 8628\u20138632 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60664_CR22","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","volume":"148","author":"D Eisenberg","year":"2012","unstructured":"Eisenberg, D. & Jucker, M. The amyloid state of proteins in human diseases. Cell 148, 1188\u20131203 (2012).","journal-title":"Cell"},{"key":"60664_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"K Jackson","year":"2013","unstructured":"Jackson, K. et al. Amylin deposition in the brain: A second amyloid in Alzheimer disease? Ann. Neurol. 74, 517\u2013526 (2013).","journal-title":"Ann. Neurol."},{"key":"60664_CR24","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1210\/en.2010-0590","volume":"151","author":"JL Trevaskis","year":"2010","unstructured":"Trevaskis, J. L. et al. Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats. Endocrinol. 151, 5657\u20135668 (2010).","journal-title":"Endocrinol."},{"key":"60664_CR25","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.febslet.2008.05.006","volume":"582","author":"YA Lim","year":"2008","unstructured":"Lim, Y. A., Ittner, L. M., Lim, Y. L. & G\u00f6tz, J. Human but not rat amylin shares neurotoxic properties with A\u03b242 in long-term hippocampal and cortical cultures. FEBS Lett. 582, 2188\u20132194 (2008).","journal-title":"FEBS Lett."},{"key":"60664_CR26","doi-asserted-by":"publisher","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","volume":"287","author":"W Fu","year":"2012","unstructured":"Fu, W. et al. Amyloid \u03b2 (A\u03b2) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways. J. Biol. Chem. 287, 18820\u201318830 (2012).","journal-title":"J. Biol. Chem."},{"key":"60664_CR27","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu, W. Q. et al. Insulin-degrading enzyme regulates extracellular levels of amyloid \u03b2- protein by degradation. J. Biol. Chem. 273, 32730\u201332738 (1998).","journal-title":"J. Biol. Chem."},{"key":"60664_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","volume":"185","author":"ME Oskarsson","year":"2015","unstructured":"Oskarsson, M. E. et al. In vivo seeding and cross-seeding of localized amyloidosis: A molecular link between type 2 diabetes and Alzheimer disease. Am. J. Pathol. 185, 834\u2013846 (2015).","journal-title":"Am. J. Pathol."},{"key":"60664_CR29","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3233\/JAD-160800","volume":"56","author":"LA Mohamed","year":"2017","unstructured":"Mohamed, L. A. et al. Amylin enhances amyloid-\u03b2 peptide brain to blood efflux across the blood-brain barrier. J. Alzheimer\u2019s Dis. 56, 1087\u20131099 (2017).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"60664_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3233\/JAD-160677","volume":"56","author":"E Wang","year":"2017","unstructured":"Wang, E. et al. Amylin treatment reduces neuroinflammation and ameliorates abnormal patterns of gene expression in the cerebral cortex of an Alzheimer\u2019s disease mouse model. J. Alzheimer\u2019s Dis. 56, 47\u201361 (2017).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"60664_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuropharm.2017.03.030","volume":"119","author":"H Zhu","year":"2017","unstructured":"Zhu, H. et al. Amylin receptor ligands reduce the pathological cascade of Alzheimer\u2019s disease. Neuropharmacol. 119, 170\u2013181 (2017).","journal-title":"Neuropharmacol."},{"key":"60664_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/mp.2014.17","volume":"20","author":"H Zhu","year":"2015","unstructured":"Zhu, H. et al. Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease. Mol. Psychiatry 20, 252\u2013262 (2015).","journal-title":"Mol. Psychiatry"},{"key":"60664_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep34505","volume":"6","author":"T Yamaguchi","year":"2016","unstructured":"Yamaguchi, T. et al. Expression of B4GALNT1, an essential glycosyltransferase for the synthesis of complex gangliosides, suppresses BACE1 degradation and modulates APP processing. Sci. Rep. 6, 34505 (2016).","journal-title":"Sci. Rep."},{"key":"60664_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnagi.2013.00038","volume":"5","author":"J G\u00f6tz","year":"2013","unstructured":"G\u00f6tz, J., Lim, Y. A. & Eckert, A. Lessons from two prevalent amyloidoses- What amylin and A\u03b2 have in common. Front. Aging Neurosci. 5, 38\u201347 (2013).","journal-title":"Front. Aging Neurosci."},{"key":"60664_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1567205012666141218140953","volume":"12","author":"RJ Baranello","year":"2015","unstructured":"Baranello, R. J. et al. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer\u2019s disease. Curr. Alzheimer Res. 12, 32\u201346 (2015).","journal-title":"Curr. Alzheimer Res."},{"key":"60664_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","volume":"27","author":"WQ Qiu","year":"2006","unstructured":"Qiu, W. Q. & Folstein, M. F. Insulin, insulin-degrading enzyme and amyloid-\u03b2 peptide in Alzheimer\u2019s disease: Review and hypothesis. Neurobiol. Aging 27, 190\u2013198 (2006).","journal-title":"Neurobiol. Aging"},{"key":"60664_CR37","doi-asserted-by":"publisher","first-page":"e71702","DOI":"10.1371\/journal.pone.0071702","volume":"8","author":"C Grossi","year":"2013","unstructured":"Grossi, C. et al. The polyphenol oleuropein aglycone protects TgCRND8 mice against A\u00df plaque pathology. PLoS One 8, e71702 (2013).","journal-title":"PLoS One"},{"key":"60664_CR38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","volume":"19","author":"WA Banks","year":"1998","unstructured":"Banks, W. A. & Kastin, A. J. Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin. Peptides 19, 883\u2013889 (1998).","journal-title":"Peptides"},{"key":"60664_CR39","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1124\/pr.115.010629","volume":"67","author":"DL Hay","year":"2015","unstructured":"Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G. & Roth, J. D. Amylin: pharmacology, physiology, and clinical potential. Pharmacol. Rev. 67, 564\u2013600 (2015).","journal-title":"Pharmacol. Rev."},{"key":"60664_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neuroscience.2017.05.024","volume":"356","author":"WQ Qiu","year":"2017","unstructured":"Qiu, W. Q. Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer\u2019s disease. Neurosci. 356, 44\u201351 (2017).","journal-title":"Neurosci."},{"key":"60664_CR41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","volume":"35","author":"BL Adler","year":"2014","unstructured":"Adler, B. L. et al. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer\u2019s disease pathogenesis and cognition. Neurobiol. Aging 35, 793\u2013801 (2014).","journal-title":"Neurobiol. Aging"},{"key":"60664_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnagi.2013.00042","volume":"5","author":"W Fu","year":"2013","unstructured":"Fu, W., Patel, A. & Jhamandas, J. H. Amylin receptor: A common pathophysiological target in Alzheimer\u2019s disease and diabetes mellitus. Front. Aging Neurosci. 5, 42\u201345 (2013).","journal-title":"Front. Aging Neurosci."},{"key":"60664_CR43","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1523\/JNEUROSCI.1051-04.2004","volume":"24","author":"JH Jhamandas","year":"2004","unstructured":"Jhamandas, J. H. Antagonist of the amylin receptor blocks -amyloid toxicity in rat cholinergic basal forebrain neurons. J. Neurosci. 24, 5579\u20135584 (2004).","journal-title":"J. Neurosci."},{"key":"60664_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JAD-160047","volume":"53","author":"N Verma","year":"2016","unstructured":"Verma, N. et al. Intraneuronal amylin deposition, peroxidative membrane injury and increased il-1\u03b2 synthesis in brains of alzheimer\u2019s disease patients with type-2 diabetes and in diabetic hip rats. J. Alzheimer\u2019s Dis. 53, 259\u2013272 (2016).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"60664_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.trci.2016.11.005","volume":"3","author":"R Soudy","year":"2016","unstructured":"Soudy, R. et al. Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. Transl. Res. Clin. Interv. 3, 44\u201356 (2016).","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"60664_CR46","doi-asserted-by":"publisher","first-page":"17401","DOI":"10.1523\/JNEUROSCI.3028-12.2012","volume":"32","author":"R Kimura","year":"2012","unstructured":"Kimura, R., MacTavish, D., Yang, J., Westaway, D. & Jhamandas, J. H. Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor. J. Neurosci. 32, 17401\u201317406 (2012).","journal-title":"J. Neurosci."},{"key":"60664_CR47","first-page":"20269","volume":"279","author":"J Davis","year":"2004","unstructured":"Davis, J. et al. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid beta-protein precursor. J. Biol. Chem. 279, 20269\u201320306 (2004).","journal-title":"J. Biol. Chem."},{"key":"60664_CR48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuron.2014.02.027","volume":"82","author":"S Hong","year":"2014","unstructured":"Hong, S. et al. Soluble A\u03b2 oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes. Neuron 82, 308\u2013319 (2014).","journal-title":"Neuron"},{"key":"60664_CR49","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.bbamem.2007.01.018","volume":"1768","author":"K Yanagisawa","year":"2007","unstructured":"Yanagisawa, K. Role of gangliosides in Alzheimer\u2019s disease. Biochim. Biophys. Acta 1768, 1943\u20131951 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"60664_CR50","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1073\/pnas.0407035102","volume":"102","author":"GP Gellermann","year":"2005","unstructured":"Gellermann, G. P. et al. Raft lipids as common components of human extracellular amyloid fibrils. Proc. Natl Acad. Sci. USA 102, 6297\u20136302 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60664_CR51","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1016\/j.febslet.2009.07.044","volume":"583","author":"M Wakabayashi","year":"2009","unstructured":"Wakabayashi, M. & Matsuzaki, K. Ganglioside-induced amyloid formation by human islet amyloid polypeptide in lipid rafts. FEBS Lett. 583, 2854\u20132588 (2009).","journal-title":"FEBS Lett."},{"key":"60664_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chemphyslip.2009.03.008","volume":"160","author":"MFM Engel","year":"2009","unstructured":"Engel, M. F. M. Membrane permeabilization by Islet Amyloid Polypeptide. Chem. Phys. Lipids 160, 1\u201310 (2009).","journal-title":"Chem. Phys. Lipids"},{"key":"60664_CR53","doi-asserted-by":"publisher","first-page":"6433","DOI":"10.1021\/bi200771m","volume":"50","author":"K Ikeda","year":"2011","unstructured":"Ikeda, K., Yamaguchi, T., Fukunaga, S., Hoshino, M. & Matsuzaki, K. Mechanism of amyloid \u03b2-protein aggregation mediated by GM1 ganglioside clusters. Biochem. 50, 6433\u20136440 (2011).","journal-title":"Biochem."},{"key":"60664_CR54","doi-asserted-by":"crossref","first-page":"956104","DOI":"10.4061\/2011\/956104","volume":"2011","author":"K Matsuzaki","year":"2011","unstructured":"Matsuzaki, K. Formation of toxic amyloid fibrils by amyloid \u03b2-protein on ganglioside clusters. Int. J. Alzheimers. Dis. 2011, 956104 (2011).","journal-title":"Int. J. Alzheimers. Dis."},{"key":"60664_CR55","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/jcb.20596","volume":"96","author":"L Wu","year":"2005","unstructured":"Wu, L. & Gonias, S. L. The low-density lipoprotein receptor-related protein-1 associates transiently with lipid rafts. J. Cell. Biochem. 96, 1021\u20131033 (2005).","journal-title":"J. Cell. Biochem."},{"key":"60664_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mcn.2016.08.006","volume":"76","author":"E Laudati","year":"2016","unstructured":"Laudati, E. et al. The activities of LDL Receptor-related Protein-1 (LRP1) compartmentalize into distinct plasma membrane microdomains. Mol. Cell. Neurosci. 76, 42\u201351 (2016).","journal-title":"Mol. Cell. Neurosci."},{"key":"60664_CR57","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1128\/MCB.24.20.8872-8883.2004","volume":"24","author":"P May","year":"2004","unstructured":"May, P. et al. Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol. Cell Biol. 24, 8872\u20138883 (2004).","journal-title":"Mol. Cell Biol."},{"key":"60664_CR58","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nn1903","volume":"10","author":"A Yoshii","year":"2007","unstructured":"Yoshii, A. & Constantine-Paton, M. BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation. Nat. Neurosci. 10, 702\u2013711 (2007).","journal-title":"Nat. Neurosci."},{"key":"60664_CR59","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1111\/j.1471-4159.1993.tb07480.x","volume":"61","author":"PC May","year":"1993","unstructured":"May, P. C., Boggs, L. N. & Fuson, K. S. Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to alzheimer\u2019s disease amyloid\u2010\u03b2 neurotoxicity. J. Neurochem. 61, 2330\u20132333 (1993).","journal-title":"J. Neurochem."},{"key":"60664_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fnagi.2014.00186","volume":"6","author":"WQ Qiu","year":"2014","unstructured":"Qiu, W. Q. & Zhu, H. Amylin and its analogs: A friend or foe for the treatment of Alzheimer\u2019s disease? Front. Aging Neurosci. 6, 186\u2013194 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"60664_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/srep37063","volume":"6","author":"C Wang","year":"2016","unstructured":"Wang, C. et al. The role of posttraumatic hypothermia in preventing dendrite degeneration and spine loss after severe traumatic brain injury. Sci. Rep. 6, 37063 (2016).","journal-title":"Sci. Rep."},{"key":"60664_CR62","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jnutbio.2015.07.022","volume":"26","author":"H Qosa","year":"2015","unstructured":"Qosa, H. et al. Extra-virgin olive oil attenuates amyloid-\u03b2 and tau pathologies in the brains of TgSwDI mice. J. Nutr. Biochem. 26, 1479\u20131490 (2015).","journal-title":"J. Nutr. Biochem."},{"key":"60664_CR63","first-page":"8349","volume":"56","author":"Z Wang","year":"2015","unstructured":"Wang, Z. & Schey, K. L. Proteomic analysis of lipid raft-like detergent-resistant membranes of lens fiber cells. Investig. Ophthalmol. Vis. Sci. 56, 8349\u20138360 (2015).","journal-title":"Vis. Sci."},{"key":"60664_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00401-005-1040-6","volume":"110","author":"DR Martin","year":"2005","unstructured":"Martin, D. R. et al. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis. Acta Neuropathol. 110, 443\u2013450 (2005).","journal-title":"Acta Neuropathol."}],"updated-by":[{"DOI":"10.1038\/s41598-020-68281-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60664-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60664-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60664-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T07:28:24Z","timestamp":1722497304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60664-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60664"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60664-5","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-020-68281-y","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"assertion":[{"value":"2 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3751"}}